Ellen Gelpi

Country flagAustria

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2022

Neurodegenerative diseases are a major health burden. The underlying causes are not yet fully understood, but different mechanisms such as cell stress and chronic inflammation have been described as contributing factors. Neurodegenerative changes have been observed in the vicinity of brain tumors, typically around slowly growing benign lesions. Moreover, in‐vitro data suggest a potential induction of pathological tau deposits also in glioblastoma, a highly malignant and proliferative brain cancer. The aim of this study was to evaluate neurodegeneration‐associated protein deposition and autophagy as well as microglial activation within and surrounding glioblastoma. Post‐mortem brain tissue of 22 patients with glioblastoma was evaluated immunohistochemically for phosphorylated tau, beta‐amyloid, alpha‐synuclein and phosphorylated TDP‐43. Additionally, the autophagy marker p62 and the microglial marker HLA‐DR were investigated. The data was compared to 22 control cases and ten cases with other space occupying brain lesions. An increase of p62‐immunoreactivity was observed within and adjacent to the glioblastoma tumor tissue. Moreover, dense microglial infiltration in the tumor tissue and the immediate surrounding brain tissue was a constant feature. Deposition of neurodegeneration‐associated proteins was found in the majority of cases (86.4%) but in distant sites. These findings suggested a preexisting neurodegenerative pathology, which followed a typical distributional pattern: ten cases with Alzheimer disease neuropathological changes, including two severe cases, eight cases with primary age‐related tauopathy, six cases with aging‐related tau astrogliopathy and one case with progressive supranuclear palsy. Collectively, our data suggests enhanced autophagy in glioblastoma tumor cells and the surrounding brain. The variety and distribution of distant neurodegeneration‐associated protein aggregates observed in the majority of cases, suggest a preexisting rather than a tumor‐induced neurodegenerative condition.

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

Raquel Ruiz-García

-

SPAIN
View details

Renate Kain

Medical University of Vienna

AUSTRIA
View details

Guenter Weiss

Director, full professor

Medical University of Innsbruck

AUSTRIA
View details

Gregor Gorkiewicz

Medical University of Graz

AUSTRIA
View details

Matthias Preusser

Medical University

AUSTRIA
View details

Teresa Ximelis Malondra

Fundació Institut d'Investigació Sanitària Illes Balears

SPAIN
View details

Johannes Kläger

Medical University of Vienna

AUSTRIA
View details

Adelheid Woehrer

Professor

Medical University of Innsbruck

AUSTRIA
View details

K Roessler

Medical University of Vienna

AUSTRIA
View details

Thomas Roetzer-Pejrimovsky

Medical University of Vienna

AUSTRIA
View details

Virginia Casado

profesora

Universidad de Alcalá Facultad de Ciencias

SPAIN
View details

Sofia Dellavalle

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ITALY
View details

Simon Hametner

Medical University of Vienna

AUSTRIA
View details

Lucas Schirmer

W3 Heisenberg Professor of Translational Neurobiology, Division Chief Neuroimmunology, Vice Chair Academic Affairs

Ruprecht-Karls-Universität Heidelberg Medizinische Fakultät Mannheim

GERMANY
View details

Alexander Micko

Medical University of Graz

AUSTRIA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.